Guidance, NICE advice and quality standards in development | Guidance

Showing 21 to 30 of 302

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Autologous chondrocyte implantation using 3D collagen matrix (novocart 3D) for treating articular cartilage defects of the knee [ID2707]	Technology appraisal guidance	TBC
Avacincaptad pegol for treating geographic atrophy caused by age-related macular degeneration [ID6401]	Technology appraisal guidance	TBC
Avapritinib for treating inadequately controlled moderate to severe indolent systemic mastocytosis [ID6578]	Technology appraisal guidance	TBC
Avelumab for previously treated platinum-resistant ovarian cancer [ID1497]	Technology appraisal guidance	TBC
Avelumab for untreated PD-L1 positive recurrent or metastatic non-small-cell lung cancer [ID1261]	Technology appraisal guidance	TBC
Axatilimab for treating active chronic graft-versus-host disease after 2 or more systemic treatments in people 2 years and over [ID6570]	Technology appraisal guidance	TBC
Baloxavir marboxil for preventing influenza in people 12 years and over [ID3793]	Technology appraisal guidance	TBC
Baloxavir marboxil for reducing direct transmission of influenza A or B in people 5 to 64 years [ID6552]	Technology appraisal guidance	TBC
Baloxavir marboxil for treating influenza in people 12 years and over at high risk of complications [ID3794]	Technology appraisal guidance	TBC
Baloxavir marboxil granules for treating and preventing influenza in people 3 weeks and over [GID-TA12479]	Technology appraisal guidance	TBC